SCHEMBL15469646

SCHEMBL15469646

CC(C)(C)c1ccc2cncc(O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 2/20 0.43
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
RECQL P46063 1/20 0.43
CYP2D6 P10635 2/20 0.38
LMNA P02545 1/20 0.38
TYR P14679 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLC22A12 Q96S37 2/20 0.37
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9880944 0.80 TRPV1 (0.38) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL17811246 0.80 NR1I2 (0.40) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL9880941 0.79 ALOX5AP (0.42) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL9880940 0.79 KIF11 (0.39) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL21018477 0.76 TRPV1 (0.38) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL722323 0.76 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL12114723 0.76 TRPA1 (0.46) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL28986981 0.75 CYP11B1 (0.49) LMNAKDM4EMAPKAPK2
SCHEMBL2054647 0.74 CTDSP1 (0.53) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL12056353 0.74 ALDH1A1 (0.41) ALDH1A1HPGDALOX15HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952009-B2 Chroman derivatives as TRPM8 inhibitors AMGEN INC. (US) 2015-02-10 US disclosed
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS TRPM8, TRPM5, TRPM7 ALDH1A1 4469/4885HPGD 1063/4885ALOX15 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.